1. American Cancer Society (ACS). Endometrial (Uterine) cancer. Retrieved from http://www.cancer.org/acs/groups/cid/documents/webcontent/003097-pdf (2.10.2016).
2. Angioli R, Capriglione S, Scaletta G, et al. The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program. Tumour Biol. 2016;37:4973–8.
3. Amant F, Moerman P, Neven P, Timmerman D, van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505.
4. Office for National Statistics. Cancer Survival in England 2016. Available from:https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancersurvivalinengland/adultstageatdiagnosisandchildhoodpatientsfollowedupto2016/previous/v1#cancer-survival-in-englandpatients-diagnosed-between-2011-and-2015-and-followed-up-to2016-national-statistics.
5. Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, et al. Biomarkers in endometrial cancer: possible clinical applications (review). Oncol Lett. 2012;3(6):1175–80.